Law360, New York (September 17, 2009) -- AstraZeneca Plc has asked a federal court for a ruling in its favor in a nearly 2-year-old patent infringement litigation the pharmaceutical giant has been pursuing against several generic-drug makers over its cholesterol drug Crestor.
In a motion for summary judgment filed Sept. 11 in the U.S. District Court for the District of Delaware, AstraZeneca asks the court to issue a ruling in the case...
